Nerve growth factor induces facial heat hyperalgesia and plays a role in trigeminal neuropathic pain in rats

Behavioural Pharmacology

Volumn 27, Issue 6, 2016, Pages 528-535

  Dos Reis, Renata C ^a   Kopruszinski, Caroline M ^a   Nones, Carina F M ^a   Chichorro, Juliana G ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

facial heat hyperalgesia; infraorbital nerve constriction; mast cells; nerve growth factor; rat; transient receptor potential vanilloid 1 receptors; trigeminal nerve; tyrosine kinase receptor A

Indexed keywords

COMPOUND 48-80; K 252A; N (4 TERT BUTYLPHENYL) 4 (3 CHLORO 2 PYRIDINYL) 1 PIPERAZINECARBOXAMIDE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR ANTIBODY; PROTEIN TYROSINE KINASE A; RECOMBINANT NERVE GROWTH FACTOR; VANILLOID RECEPTOR 1; 4 METHOXY N METHYLPHENETHYLAMINE; TRPV1 RECEPTOR; VANILLOID RECEPTOR;

ADULT; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG TARGETING; FACE PAIN; FACIAL NERVE; HEAT HYPERALGESIA; HEAT PAIN THRESHOLD; HYPERALGESIA; INFRAORBITAL NERVE; LIP DISEASE; LIP EDEMA; LOCAL THERAPY; MALE; MAST CELL DEGRANULATION; MEDIATOR RELEASE; MOLECULAR PATHOLOGY; MOUTH EDEMA; NERVE COMPRESSION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; RAT; REPEATED DRUG DOSE; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; TRIGEMINAL NERVE; TRIGEMINUS NEURALGIA; ANIMAL; DISEASE MODEL; HEAT; MAST CELL; METABOLISM; PATHOPHYSIOLOGY; TIME FACTOR; WISTAR RAT;

ANIMALS; DISEASE MODELS, ANIMAL; FACIAL PAIN; HOT TEMPERATURE; HYPERALGESIA; MALE; MAST CELLS; NERVE GROWTH FACTOR; P-METHOXY-N-METHYLPHENETHYLAMINE; RATS; RATS, WISTAR; RECEPTOR, TRKA; TIME FACTORS; TRIGEMINAL NEURALGIA; TRPV CATION CHANNELS;

EID: 84978174640     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0000000000000246     Document Type: Article

References (55)

1. Aloe L, Rocco ML, Balzamino BO, Micera A (2015). Nerve growth factor: a focus on neuroscience and therapy. Curr Neuropharmacol 13:294-303.
2. Amann R, Schuligoi R, Herzeg G, Donnerer J (1996). Intraplantar injection of nerve growth factor into the rat hind paw: local edema and effects on thermal nociceptive threshold. Pain 64:323-329.
3. Amaya F, Shimosato G, Nagano M, Ueda M, Hashimoto S, Tanaka Y, et al. (2004). NGF and GDNF differentially regulate TRPV1 expression that contributes to development of inflammatory thermal hyperalgesia. Eur J Neurosci 20: 2303-2310.
4. Andrade EL, Luiz AP, Ferreira J, Calixto JB (2008). Pronociceptive response elicited by TRPA1 receptor activation in mice. Neuroscience 152: 511-520.
5. Banik RK, Subieta AR, Wu C, Brennan TJ (2005). Increased nerve growth factor after rat plantar incision contributes to guarding behavior and heat hyperalgesia. Pain 117:68-76.
6. Benn SC, Costigan M, Tate S, Fitzgerald M, Woolf CJ (2001). Developmental expression of the TTX-resistant voltage-gated sodium channels Nav1.8 (SNS) and Nav1.9 (SNS2) in primary sensory neurons. J Neurosci 21: 6077-6085.
7. Bonnington JK, McNaughton PA (2003). Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J Physiol 551 (Pt 2):433-446.
8. Bowles WR, Sabino M, Harding-Rose C, Hargreaves KM (2004). Nerve growth factor treatment enhances release of immunoreactive calcitonin gene-related peptide but not substance P from spinal dorsal horn slices in rats. Neurosci Lett 363:239-242.
9. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
10. Chichorro JG, Zampronio AR, Souza GEP, Rae GA (2006). Orofacial cold hyperalgesia due to infraorbital nerve constriction injury in rats: reversal by endothelin receptor antagonists but not non-steroidal anti-inflammatory drugs. Pain 123:64-74.
11. Chichorro JG, Zampronio AR, Cabrini DA, Franco CR, Rae GA (2009). Mechanisms operated by endothelin ETA and ETB receptors in the trigeminal ganglion contribute to orofacial thermal hyperalgesia induced by infraorbital nerve constriction in rats. Neuropeptides 43:133-142.
12. Chuang HH, Prescott ED, Kong H, Shields S, Jordt SE, Basbaum AI, et al. (2001). Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns (4,5)P2-mediated inhibition. Nature 411:957-962.
13. Costa GM, de Oliveira AP, Martinelli PM, Camargos ER, Arantes RM, de Almeida-Leite CM (2016). Demyelination/remyelination and expression of interleukin-1β, substance P, nerve growth factor, and glial-derived neurotrophic factor during trigeminal neuropathic pain in rats. Neurosci Lett 612:210-218.
14. Eskander MA, Ruparel S, Green DP, Chen PB, Por ED, Jeske NA, et al. (2015). Persistent nociception triggered by nerve growth factor (NGF) is mediated by TRPV1 and oxidative mechanisms. J Neurosci 35:8593-8603.
15. Friedel RH, Schnürch H, Stubbusch J, Barde YA (1997). Identification of genes differentially expressed by nerve growth factor-and neurotrophin-3-dependent sensory neurons. Proc Natl Acad Sci USA 94:12670-12675.
16. Gould HJ, Gould TN, England JD, Paul D, Liu ZP, Levinson SR (2000). A possible role for nerve growth factor in the augmentation of sodium channels in models of chronic pain. Brain Res 854:19-29.
17. Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ (2002). p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36:57-68.
18. Kanai Y, Hara T, Imai A, Sakakibara A (2007). Differential involvement of TRPV1 receptors at the central and peripheral nerves in CFA-induced mechanical and thermal hyperalgesia. J Pharm Pharmacol 59:733-738.
19. Khan N, Smith MT (2015). Neurotrophins and neuropathic pain: role in pathobiology. Molecules 20:10657-10688.
20. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160:1577-1579.
21. Knight E Jr, Connors TJ, Maroney AC, Angeles TS, Hudkins RL, Dionne CA (1997). A radioactive binding assay for inhibitors of trkA kinase. Anal Biochem 247:376-381.
22. Lewin GR, Rueff A, Mendell LM (1994). Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur J Neurosci 6:1903-1912.
23. Ma QP, Woolf CJ (1997). The progressive tactile hyperalgesia induced by peripheral inflammation is nerve growth factor dependent. Neuroreport 8:807-810.
24. Malek N, Pajak A, Kolosowska N, Kucharczyk M, Starowicz K (2015). The importance of TRPV1-sensitisation factors for the development of neuropathic pain. Mol Cell Neurosci 65:1-10.
25. McMahon SB, Armanini MP, Ling LH, Phillips HS (1994). Expression and coexpression of Trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets. Neuron 12:1161-1171.
26. McMahon SB, Bennett DL, Priestley JV, Shelton DL (1995). The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nat Med 1:774-780.
27. Mills CD, Nguyen T, Tanga FY, Zhong C, Gauvin DM, Mikusa J, et al. (2013). Characterization of nerve growth factor-induced mechanical and thermal hypersensitivity in rats. Eur J Pain 17:469-479.
28. Oh EJ, Yoon YW, Lee SE, Hong SK (2000). Changes in nerve growth factor levels in dorsal root ganglia and spinal nerves in a rat neuropathic pain model. Exp Brain Res 130:93-99.
29. Owolabi JB, Rizkalla G, Tehim A, Ross GM, Riopelle RJ, Kamboj R, et al. (1999). Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat. J Pharmacol Exp Ther 289: 1271-1276.
30. Pelegrini-da-Silva A, Oliveira MC, Parada CA, Tambeli CH (2008). Nerve growth factor acts with the beta2-adrenoceptor to induce spontaneous nociceptive behavior during temporomandibular joint inflammatory hyperalgesia. Life Sci 83:780-785.
31. Peleshok JC, Ribeiro-da-Silva A (2012). Neurotrophic factor changes in the rat thick skin following chronic constriction injury of the sciatic nerve. Mol Pain 8:1.
32. Perin-Martins A, Teixeira JM, Tambeli CH, Parada CA, Fischer L (2013). Mechanisms underlying transient receptor potential ankyrin 1 (TRPA1)-mediated hyperalgesia and edema. J Peripher Nerv Syst 18:62-74.
33. Pezet S, McMahon SB (2006). Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 29:507-538.
34. Prescott ED, Julius D (2003). A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity. Science 300:1284-1288.
35. Price TJ, Louria MD, Candelario-Soto D, Dussor GO, Jeske NA, Patwardhan AM, et al. (2005). Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion. BMC Neurosci 6:4.
36. Ramer MS, Bisby MA (1999). Adrenergic innervation of rat sensory ganglia following proximal or distal painful sciatic neuropathy: distinct mechanisms revealed by anti-NGF treatment. Eur J Neurosci 11:837-846.
37. Ramer MS, Kawaja MD, Henderson JT, Roder JC, Bisby MA (1998). Glial overexpression of NGF enhances neuropathic pain and adrenergic sprouting into DRG following chronic sciatic constriction in mice. Neurosci Lett 251:53-56.
38. Ro LS, Chen ST, Tang LM, Jacobs JM (1999). Effect of NGF and anti-NGF on neuropathic pain in rats following chronic constriction injury of the sciatic nerve. Pain 79:265-274.
39. Rueff A, Mendell LM (1996). Nerve growth factor NT-5 induce increased thermal sensitivity of cutaneous nociceptors in vitro. J Neurophysiol 76: 3593-3596.
40. Rueff A, Dawson AJ, Mendell LM (1996). Characteristics of nerve growth factor induced hyperalgesia in adult rats: dependence on enhanced bradykinin-1 receptor activity but not neurokinin-1 receptor activation. Pain 66:359-372.
41. Rukwied R, Mayer A, Kluschina O, Obreja O, Schley M, Schmelz M (2010). NGF induces non-inflammatory localized and lasting mechanical and thermal hypersensitivity in human skin. Pain 148:407-413.
42. Shinoda M, Asano M, Omagari D, Honda K, Hitomi S, Katagiri A, Iwata K (2011). Nerve growth factor contribution via transient receptor potential vanilloid 1 to ectopic orofacial pain. J Neurosci 31:7145-7155.
43. Shu X, Mendell LM (1999). Nerve growth factor acutely sensitizes the response of adult rat sensory neurons to capsaicin. Neurosci Lett 274:159-162.
44. Shu X, Mendell LM (2001). Acute sensitization by NGF of the response of small-diameter sensory neurons to capsaicin. J Neurophysiol 86: 2931-2938.
45. Skoff AM, Adler JE (2006). Nerve growth factor regulates substance P in adult sensory neurons through both TrkA and p75 receptors. Exp Neurol 197:430-436.
46. Tal M, Liberman R (1997). Local injection of nerve growth factor (NGF) triggers degranulation of mast cells in rat paw. Neurosci Lett 221:129-132.
47. Theodosiou M, Rush RA, Zhou XF, Hu D, Walker JS, Tracey DJ (1999). Hyperalgesia due to nerve damage: role of nerve growth factor. Pain 81:245-255.
48. Ugolini G, Marinelli S, Covaceuszach S, Cattaneo A, Pavone F (2007). The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. Proc Natl Acad Sci USA 104:2985-2990.
49. Vos BP, Strassman AM, Maciewicz RJ (1994). Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat's infraorbital nerve. J Neurosci 14:2708-2723.
50. Weinkauf B, Obreja O, Schmelz M, Rukwied R (2012). Differential effects of lidocaine on nerve growth factor (NGF)-evoked heat-and mechanical hyperalgesia in humans. Eur J Pain 16:543-549.
51. Wild KD, Bian D, Zhu D, Davis J, Bannon AW, Zhang TJ, Louis JC (2007). Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance. J Pharmacol Exp Ther 322:282-287.
52. Woolf CJ, Safieh-Garabedian B, Ma QP, Crilly P, Winter J (1994). Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 62:327-331.
53. Woolf CJ, Ma QP, Allchorne A, Poole S (1996). Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation. J Neurosci 16:2716-2723.
54. Zhang X, Huang J, McNaughton PA (2005). NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J 24:4211-4223.
55. Zimmermann M (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110.